Study programme 2020-2021 | Français | ||
Pharmacochimie: études des médicaments organiques - Partie 2 | |||
Programme component of Master's in Pharmacy à la Faculty of Medicine and Pharmacy |
Students are asked to consult the ECTS course descriptions for each learning activity (AA) to know what special Covid-19 assessment methods are possibly planned for the end of Q3 |
---|
Code | Type | Head of UE | Department’s contact details | Teacher(s) |
---|---|---|---|---|
UM-M1-PHARMA-009-M | Compulsory UE | BERGER Gilles | EX12 - Université Libre de Bruxelles |
|
Language of instruction | Language of assessment | HT(*) | HTPE(*) | HTPS(*) | HR(*) | HD(*) | Credits | Weighting | Term |
---|---|---|---|---|---|---|---|---|---|
| Français | 60 | 0 | 0 | 0 | 0 | 5 | 5.00 | 1st term |
AA Code | Teaching Activity (AA) | HT(*) | HTPE(*) | HTPS(*) | HR(*) | HD(*) | Term | Weighting |
---|---|---|---|---|---|---|---|---|
M-DOYM-022 | Pharmacochimie: études des médicaments organiques - Partie 2 | 45 | 0 | 0 | 0 | 0 | Q1 | |
M-DOYM-080 | Etude des médicaments d'origine biologique | 15 | 0 | 0 | 0 | 0 | Q1 |
Programme component |
---|
Objectives of Programme's Learning Outcomes
Prior Experience
Not applicable
Type of Resit Assessment for UE in Q1 (BAB1)
Q1 UE Resit Assessment Comments (BAB1)
Sans objet
Type of Teaching Activity/Activities
AA | Type of Teaching Activity/Activities |
---|---|
M-DOYM-022 |
|
M-DOYM-080 |
|
Mode of delivery
AA | Mode of delivery |
---|---|
M-DOYM-022 |
|
M-DOYM-080 |
|
Required Reading
AA | |
---|---|
M-DOYM-022 | |
M-DOYM-080 |
Required Learning Resources/Tools
AA | Required Learning Resources/Tools |
---|---|
M-DOYM-022 | Not applicable |
M-DOYM-080 | Powerpoint (available on Moodle) |
Recommended Reading
AA | |
---|---|
M-DOYM-022 | |
M-DOYM-080 |
Recommended Learning Resources/Tools
AA | Recommended Learning Resources/Tools |
---|---|
M-DOYM-022 | Not applicable |
M-DOYM-080 | CBIP Analytical characterization of biotherapeutics - Wiley ; 2017 ISBN: 978-1-119-05310-1 Directive 2001/83/EC, https://ec.europa.eu/health/documents/eudralex/vol-1_fr |
Other Recommended Reading
AA | Other Recommended Reading |
---|---|
M-DOYM-022 | Not applicable |
M-DOYM-080 | Not applicable |